3billion shares surge 23.06% after Korean ARPA-H rare-disease project selection
AI Summary- 3billion joined Korea’s ARPA-H rare-disease treatment-development project as a joint research institution.
- 5,790 Korean won represented a 23.06% gain on KOSDAQ at 9:49 a.m. September 23.
- KAIST leads the four-year-six-month project with 3billion and Seoul Asan Hospital.